12:00 AM
Sep 10, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Humira adalimumab regulatory update

Abbott and partner Eisai said Japan's Ministry of Health, Labor and Welfare (MHLW) approved a regulatory application to extend the label of Humira adalimumab to include...

Read the full 110 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >